Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lilly Sarafem PMDD Therapy Approved With Patient Package Insert

Executive Summary

Lilly's pre-menstrual dysphoric disorder packaging for fluoxetine (Sarafem) will include a patient package insert.

You may also be interested in...



Viagra’s Second Wind: Pfizer Revatio Approved For Pulmonary Hypertension

Pfizer's post-marketing commitments for Revatio include submitting a plan to educate health care providers that the pulmonary arterial hypertension therapy has the same active ingredient as the erectile dysfunction drug Viagra

Viagra’s Second Wind: Pfizer Revatio Approved For Pulmonary Hypertension

Pfizer's post-marketing commitments for Revatio include submitting a plan to educate health care providers that the pulmonary arterial hypertension therapy has the same active ingredient as the erectile dysfunction drug Viagra

Lilly Sarafem

Pricing of fluoxetine for pre-menstrual dysphoric disorder is identical to Prozac at about $2.72 per 20 mg capsule. Launched the week of Aug. 14, Sarafem 10 mg and 20 mg are available in blister packs of 28 capsules, which facilitates inclusion of a patient package insert, the company said. Prozac is primarily supplied in bottles of 30 capsules (1"The Pink Sheet" July 10, p. 3)

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036304

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel